112 related articles for article (PubMed ID: 20623784)
1. Rinseback during red blood cell exchange with COBE Spectra does not affect fraction of cells remaining or post-exchange hematocrit.
Bhagat R; Matevosyan K; Jones R; Vetus ML; Burner J; Sarode R
J Clin Apher; 2010; 25(6):347-9. PubMed ID: 20623784
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the depletion-red cell exchange program with the Spectra Optia and the isovolemic hemodilution-red cell exchange method with the COBE Spectra in sickle cell disease patients.
Poullin P; Sanderson F; Bernit E; Brun M; Berdah Y; Badens C
J Clin Apher; 2016 Oct; 31(5):429-33. PubMed ID: 26274351
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Spectra Optia and COBE Spectra apheresis systems' performances for red blood cell exchange procedures.
Kim J; Joseph R; Matevosyan K; Sarode R
Transfus Apher Sci; 2016 Dec; 55(3):368-370. PubMed ID: 27789125
[TBL] [Abstract][Full Text] [Related]
4. Advantages of isovolemic hemodilution-red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patients.
Sarode R; Matevosyan K; Rogers ZR; Burner JD; Rutherford C
J Clin Apher; 2011; 26(4):200-7. PubMed ID: 21786315
[TBL] [Abstract][Full Text] [Related]
5. Isovolemic hemodilution-red cell exchange for prevention of cerebrovascular accident in sickle cell anemia: the standard operating procedure.
Matevosyan K; Anderson C; Sarode R
J Clin Apher; 2012; 27(2):88-92. PubMed ID: 22302664
[TBL] [Abstract][Full Text] [Related]
6. Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
Ziemba Y; Xu C; Fomani KM; Nandi V; Yuan T; Rehmani S; Sachais BS; Appiah-Kubi AO; Aygun B; Louie JE; Shi PA
Transfusion; 2021 Feb; 61(2):526-536. PubMed ID: 33368343
[TBL] [Abstract][Full Text] [Related]
7. Erythrocytapheresis (red cell exchange).
Sentinella K; Thompson R; Hunt D; Simpson L; Marshall CE
Prog Clin Biol Res; 1982; 106():425-35. PubMed ID: 7178144
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease.
Quirolo K; Bertolone S; Hassell K; Howard T; King KE; Rhodes DK; Bill J
Transfusion; 2015 Apr; 55(4):775-81. PubMed ID: 25330984
[TBL] [Abstract][Full Text] [Related]
9. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
10. [Effective erythrocyte exchange by means of a cell separator in sickle cell anemia].
Schneider C; Rath B; Jürgens H; Brauer P; Ostkamp-Ostermann P; Sibrowski W
Beitr Infusionsther Transfusionsmed; 1994; 32():378-81. PubMed ID: 9480128
[TBL] [Abstract][Full Text] [Related]
11. Planning an exchange transfusion in patients with sickle cell syndromes.
Piomelli S; Seaman C; Ackerman K; Yu E; Blei F
Am J Pediatr Hematol Oncol; 1990; 12(3):268-76. PubMed ID: 2240473
[TBL] [Abstract][Full Text] [Related]
12. [Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange].
Driss F; Tertian G; Becquemont L; Haddad B; Cynober T; Raphael M; Tchernia G
Transfus Clin Biol; 2007 Oct; 14(4):386-92. PubMed ID: 18035571
[TBL] [Abstract][Full Text] [Related]
13. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
Thurston GB; Henderson NM; Jeng M
Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
[TBL] [Abstract][Full Text] [Related]
14. Cell separators for red cell exchange.
Klein HG
Prog Clin Biol Res; 1982; 98():109-16. PubMed ID: 7146016
[No Abstract] [Full Text] [Related]
15. Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood.
Raciti PM; Francis RO; Spitalnik PF; Schwartz J; Jhang JS
J Clin Apher; 2013 Aug; 28(4):325-9. PubMed ID: 23450789
[TBL] [Abstract][Full Text] [Related]
16. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
Thurston GB; Henderson NM; Jeng M
Clin Hemorheol Microcirc; 2004; 30(2):83-97. PubMed ID: 15004333
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the benefits of isovolemic hemodilution red cell exchange for sickle cell disease.
Reddy MS; Alkashash A; Nord A; Tetrick A
J Clin Apher; 2023 Oct; 38(5):522-528. PubMed ID: 37092306
[TBL] [Abstract][Full Text] [Related]
18. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
[TBL] [Abstract][Full Text] [Related]
19. Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease.
Rogers K; Alsawas M; Chapman J; Schlueter AJ; Knudson CM
Transfusion; 2024 Apr; 64(4):685-692. PubMed ID: 38506484
[TBL] [Abstract][Full Text] [Related]
20. Partial red cell exchange transfusion in sickle cell disease.
Klein HG; Winslow RM
Prog Clin Biol Res; 1982; 88():235-43. PubMed ID: 7100214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
